SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-23-006015
Filing Date
2023-10-03
Accepted
2023-10-03 16:05:41
Documents
11
Period of Report
2023-10-03

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_100323.htm 6-K 20351
2 EXHIBIT 4.1 exh_41.htm EX-4.1 90186
3 EXHIBIT 4.2 exh_42.htm EX-4.2 95198
4 EXHIBIT 4.3 exh_43.htm EX-4.3 98232
5 EXHIBIT 4.4 exh_44.htm EX-4.4 97715
6 EXHIBIT 4.5 exh_45.htm EX-4.5 94985
7 EXHIBIT 5.1 exh_51.htm EX-5.1 32775
8 EXHIBIT 5.2 exh_52.htm EX-5.2 11710
9 EXHIBIT 10.1 exh_101.htm EX-10.1 232360
10 GRAPHIC fhlogo.jpg GRAPHIC 5647
11 GRAPHIC hoganlovellslogo.jpg GRAPHIC 8406
  Complete submission text file 0001171843-23-006015.txt   794354
Mailing Address 6 ADELAIDE ST. EAST SUITE 300 TORONTO A6 M5C 1H6
Business Address 6 ADELAIDE ST. EAST SUITE 300 TORONTO A6 M5C 1H6 416-737-7600
PORTAGE BIOTECH INC. (Filer) CIK: 0001095435 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40086 | Film No.: 231303519
SIC: 1311 Crude Petroleum & Natural Gas